User profiles for Scott M Leighow
Scott LeighowPenn State University Verified email at psu.edu Cited by 110 |
[HTML][HTML] Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts
Background When three SARS-CoV-2 vaccines came to market in Europe and North
America in the winter of 2020–2021, distribution networks were in a race against a major …
America in the winter of 2020–2021, distribution networks were in a race against a major …
Single-molecule sequencing reveals patterns of preexisting drug resistance that suggest treatment strategies in Philadelphia-positive leukemias
MW Schmitt, JR Pritchard, SM Leighow, BI Aminov… - Clinical Cancer …, 2018 - AACR
Purpose: Sequential treatment with targeted therapies can result in complex combinations
of resistance mutations in drug targets. This mutational complexity has spurred the …
of resistance mutations in drug targets. This mutational complexity has spurred the …
SARS-CoV-2 epidemic after social and economic reopening in three US states reveals shifts in age structure and clinical characteristics
State-level reopenings in late spring 2020 facilitated the resurgence of severe acute
respiratory syndrome coronavirus 2 transmission. Here, we analyze age-structured case, …
respiratory syndrome coronavirus 2 transmission. Here, we analyze age-structured case, …
[PDF][PDF] Multi-scale predictions of drug resistance epidemiology identify design principles for rational drug design
Rationally designing drugs that last longer in the face of biological evolution is a critical
objective of drug discovery. However, this goal is thwarted by the diversity and stochasticity of …
objective of drug discovery. However, this goal is thwarted by the diversity and stochasticity of …
Deciphering the Mechanistic Basis for Perfluoroalkyl‐Protein Interactions
Although rarely used in nature, fluorine has emerged as an important elemental ingredient
in the design of proteins with altered folding, stability, oligomerization propensities, and …
in the design of proteins with altered folding, stability, oligomerization propensities, and …
[HTML][HTML] Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts
As three SARS-CoV-2 vaccines come to market in Europe and North America in the winter of
2020–2021, distribution networks will be in a race against a major epidemiological wave of …
2020–2021, distribution networks will be in a race against a major epidemiological wave of …
[PDF][PDF] Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing
C Liu, SM Leighow, K McIlroy, M Lu, KA Dennis… - Cell Reports …, 2023 - cell.com
Drug repositioning seeks to leverage existing clinical knowledge to identify alternative clinical
settings for approved drugs. However, repositioning efforts fail to demonstrate improved …
settings for approved drugs. However, repositioning efforts fail to demonstrate improved …
Agent-based models help interpret patterns of clinical drug resistance by contextualizing competition between distinct drug failure modes
Introduction Modern targeted cancer therapies are carefully crafted small molecules. These
exquisite technologies exhibit an astonishing diversity of observed failure modes (drug …
exquisite technologies exhibit an astonishing diversity of observed failure modes (drug …
Exploiting the “survival of the likeliest” to enable evolution-guided drug design
Theoretical treatments of evolutionary dynamics tend to model the probability that a single “resistant”
species will arise in a population. However, experimental studies have identified a …
species will arise in a population. However, experimental studies have identified a …
SARS-CoV-2 attack rate and population immunity in southern New England, March 2020-May 2021 (preprint)
Estimating an infectious disease attack rate requires inference on the number of reported
symptomatic cases of a disease, the number of unreported symptomatic cases, and the number …
symptomatic cases of a disease, the number of unreported symptomatic cases, and the number …